CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10,679 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02155491
NCT02155491N/ACompleted

Global Anticoagulant Registry in the Field Observing Treatment and Outcomes in Patients With Treated Acute Venous Thromboembolic Events in the Real World

Thrombosis Research Institute·observational·Posted Jun 4, 2014·Updated May 5, 2021

In Brief

An observational study for Venous Thromboembolism and 2 related conditions. Completed, enrolled 10,679 participants across 1 site.

Detailed Summary

The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: * treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) * Rate of early and late symptomatic VTE recurrence * Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension * Rate of bleeding complications * Rate of all-cause mortality at six months

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsBayer

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 4, 2014
Enrollment StartJul 7, 2014
Primary CompletionJan 4, 2020
Study CompletionSep 30, 2020
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.1 years ago